Chen Ning Yang, Chinese-American physicist and Nobel laureate, dies at 103

Chen Ning Yang, one of the world’s most renowned physicists and a Nobel prize winner, died on Saturday in Beijing at the age of 103 after an illness, state media outlet Xinhua has reported. Born in eastern China’s Hefei in Anhui province in 1922, Yang was a Chinese-American physicist who worked on statistical mechanics and symmetry principles in elementary particle physics. Yang shared the 1957 Nobel prize for physics with Tsung-Dao Lee, who died in 2024. They were awarded the prize for work that overthrew the widely accepted “parity laws”…

The Guardian view on Merck’s exit: Britain’s biopharma strategy stalls in the face of China’s rise | Editorial

The industry’s retreat from the UK reflects a deeper shift about how Beijing is rewriting the rules of innovation When Merck abruptly scrapped its billion-pound London research hub last week, critics blamed Britain’s lacklustre support for life sciences and a Scrooge-like grip on NHS drug prices. But one important factor may have been missed. That Merck, which is also cutting jobs elsewhere – 6,000 globally – is recalibrating not just in response to the UK or the US, but to China. Merck’s cash cow is pembrolizumab (brand name Keytruda), an…

Billion-dollar coffins? New technology could make oceans transparent and Aukus submarines vulnerable

Military history is littered with the corpses of apex predators. The Gatling gun, the battleship, the tank. All once possessed unassailable power – then were undermined, in some cases wiped out, by the march of new technology. “Speed and stealth and firepower,” the head of the Australian Submarine Agency, Jonathan Mead, told the Guardian two years ago of Australia’s forthcoming fleet of nuclear submarines. “The apex predator of the oceans.” But for how much longer? In the first quarter of the 21st century, nuclear submarines have proven a formidable force:…

Brainless bodies and pig organs: does science back up Putin and Xi’s longevity claims?

Perhaps it was the extravagant display of deadly weaponry that prompted Xi Jinping and Vladimir Putin to mull on mortality at this week’s military parade in Beijing. It was more banter than serious discussion, but with both aged 72, the Chinese president and his Russian counterpart may feel the cold hand on the shoulder more than Kim Jong-un, the 41-year-old North Korean leader who strolled beside them. Speaking through a interpreter, Xi told Putin that 70 is considered young today, prompting Putin to claim that human organs can now be…

Healthy living, science and an army of doctors: Putin’s pursuit of longevity

It was the stuff of Bond villains. Two ageing autocrats, their younger ally in tow, ambled down a red-carpeted ramp before a military parade in Beijing when a hot mic picked up a question that seemed to be on their minds: how long could they keep going – and, between the lines, might science allow them to rule for ever? With advances in technology, Russia’s Vladimir Putin assured Xi Jinping via his translator that “human organs can be constantly transplanted, to the extent that people can get younger, perhaps even…

Oxford University Press to stop publishing China-sponsored science journal

Oxford University Press (OUP) will no longer publish a controversial academic journal sponsored by China’s Ministry of Justice after years of concerns that several papers in the publication did not meet ethical standards about DNA collection. A statement published on the website of Forensic Sciences Research (FSR) states that OUP will stop publishing the quarterly journal after this year. FSR is a journal that comes from China’s Academy of Forensic Science, an agency that sits under the Ministry of Justice. The academy describes FSR as “the only English quarterly journal…

Swarms of tiny nose robots could clear infected sinuses, researchers say

Swarms of tiny robots, each no larger than a speck of dust, could be deployed to cure stubborn infected sinuses before being blown out through the nose into a tissue, researchers have claimed. The micro-robots are a fraction of the width of a human hair and have been inserted successfully into animal sinuses in pre-clinical trials by researchers at universities in China and Hong Kong. Swarms are injected into the sinus cavity via a duct threaded through the nostril and guided to their target by electromagnetism, where they can be…

US arrests another Chinese scientist for allegedly smuggling biological material

A Chinese scientist was arrested while arriving in the US at the Detroit airport, the second case in days involving the alleged smuggling of biological material, authorities said on Monday. The scientist is accused of shipping biological material months ago to staff at a laboratory at the University of Michigan. The FBI, in a court filing, described it as material related to certain worms and requires a government permit. “The guidelines for importing biological materials into the US for research purposes are stringent, but clear, and actions like this undermine…

Geologically complex regions more prone to landslides, study suggests

We know that steep slopes and heavy rain help to trigger landslides, but are some types of landscape more susceptible than others? A study suggests that geologically complex regions are more likely to produce landslides. Yifan Zhang, from the Institute of Mountain Hazards and Environment in Chengdu, China, and colleagues developed an index of geological complexity that combines four different geological components: lithologic complexity (number of different rock types per unit area); tectonic complexity (density of faults); seismicity (probability of earthquake activity); and structural complexity (how disordered the rock structures…

New daily weight-loss pill shows success at clinical trial

A significant trial of a daily weight-loss pill has found that it helped people to shed the pounds and reduce their blood sugar levels, making it a contender to join the new wave of drugs that combat obesity and diabetes. People who took a 36mg pill of orforglipron lost an average of 7.3kg (16lbs) over nine months, according to results from a phase 3 clinical trial reported by the drug’s manufacturer, Eli Lilly, on Thursday. The trial, which enrolled 559 obese people with type 2 diabetes from the US, China,…